DOC: DACLATASVIR FOR TREATING CHRONIC HEPATITIS C


Daclatasvir is recommended as an option for treating chronic hepatitis C in adults, as specified in table 1, only if the compan y provides daclatasvir at the same price or lower than that agreed with the Commercial Medicines Unit.... Document/File: .pdf, filesize: n/a. Filetype: pdf. Filename: daclatasvir-for-treating-chronic-hepatitis-c. Title: Daclatasvir for treating chronic hepatitis C. 2014.

 

File Info:

  • Filesize: N/A
  • Source: nice_dot_org_dot_uk
  •   Date Archived: 2017-05-27
  •   Author: N/A
 
 
 
 
 

Related Files:

 

  EPIDEMIOLOGY AND PREVENTION OF HEPATITIS B VIRUS INFECTION

... HEPATITIS B IS ONE OF THE MOST COMMON INFECTIOUS DISEASES GLOBALLY. IT HAS BEEN ESTIMATED THAT THERE ARE 350 MILLION CHRONIC HEPATITIS B VIRUS (HBV) CARRIERS WORLDWIDE. THE PREVALENCE OF CHRONIC HBV INFECTION VARIES GEOGRAPHICALLY, FROM HIGH (>8%), INTERMEDIATE (2-7%) TO LOW (<2%) PREVALENCE. ...
  epidemiology-and-prevention-of-hepatitis-b-virus-infection     PDF     2017-05-28  
 

 

  HEPATITIS B VIRUS BIOLOGY

... HEPATITIS B VIRUS (HBV) CAUSES TRANSIENT AND CHRONIC INFECTIONS OF THE LIVER. TRANSIENT INFECTIONS MAY PRODUCE SERIOUS ILLNESS, AND APPROXIMATELY 0.5% TERMINATE WITH FATAL, FULMINANT HEPATITIS. CHRONIC INFECTIONS MAY ALSO HAVE SERIOUS CONSEQUENCES: NEARLY 25% TERMINATE IN UNTREATABLE LIVER CANCER (10). WORLDWIDE DEATHS FROM LIVER CANCER CAUSED BY HBV INFECTION PROBABLY EXCEED ONE MILLION PER YEAR (52, 162). ...
  hepatitis-b-virus-biology     PDF     2017-05-28  
 

 

  HEPATITIS B VIRUS REPLICATION AND INTEGRATION

... CHRONIC INFECTION WITH HEPATITIS B VIRUS (HBV) AFFECTS 240 MILLION PEOPLE WORLDWIDE AND MAY CAUSE LIVER DISEASE INCLUDING HEPATOCELLULAR CARCINOMA (HCC). INITIALLY PATIENTS HAVE HIGH LEVELS OF HBV DNA IN THEIR BLOOD, NO LIVER DISEASE AND EXPRESS THE E ANTIGEN (HBEAG). ...
  hepatitis-b-virus-replication-and-integration     PDF     2017-05-28  
 

 

  CLINICAL GUIDELINES ON THE MANAGEMENT OF HEPATITIS C

... PATIENTS INFECTED WITH HEPATITIS C VIRUS (HCV) SHOULD BE REFERRED TO A CLINICIAN WITH A PARTICULAR INTEREST IN THE INFECTION. PATIENTS MUST HAVE ACCESS TO ADEQUATE COUNSELLING FROM A HEALTH CARER WITH KNOWLEDGE AND EXPERIENCE OF CHRONIC HCV INFECTION. ALL PATIENTS MUST HAVE ACCESS TO THE APPROPRIATE DIAGNOSTIC AND THERAPEUTIC OPTIONS AVAILABLE IN THE MANAGEMENT OF HCV INFECTION. ...
  clinical-guidelines-on-the-management-of-hepatitis-c     PDF     2017-05-27  
 

 

  HEPATITIS B IMMUNE GLOBULIN

... PREVENTS HEPATITIS B INFECTION INPATIENTS WHO ARE KNOWN TO HAVE BEEN EXPOSED, INCLUDING NEONATES BORN TO HBSAG-POSITIVE WOMEN, BY PROVIDING PASSIVE IMMUNITY. ACTION AN IMMUNE GAMMA-GLOBULIN FRACTION CONTAINING HIGH TITERS OF ANTIBODIES TO THE HEPATITIS B SURFACE ANTIGEN. CONFERS PASSIVE IMMUNITY TO HEPATITIS B INFECTION. THERAPEUTIC EFFECTS: PREVENTION OF HEPATITIS B INFECTION. ...
  hepatitis-b-immune-globulin     PDF     2017-05-27  
 

 

  HEPATITIS B IMMUNE GLOBULIN (HUMAN)

... HEPATITIS B IMMUNE GLOBULIN (HUMAN) — HYPERHEPB® S/D TREATED WITH SOLVENT/DETERGENT IS A COLORLESS TO PALE YELLOW OR PINK STERILE SOLUTION OF HEPATITIS B HYPERIMMUNE IMMUNE GLOBULIN FOR INTRAMUSCULAR ADMINISTRATION; IT IS PRESERVATIVE-FREE AND LATEX-FRE ...
  hepatitis-b-immune-globulin-human     PDF     2017-05-27  
 

 

  HEPATITIS B VIRUS: EPIDEMIOLOGY AND TRANSMISSION RISKS

... HEPATITIS B VIRUS (HBV) INFECTION IS A SERIOUS AND COMMON INFECTIOUS DISEASE OF THE LIVER, AFFECTING MILLIONS OF PEOPLE THROUGHOUT THE WORLD. THE INCUBATION PERIOD FOR HBV IS 45-180 DAYS, MOST COMMONLY 60-90 DAYS. ...
  hepatitis-b-virus-epidemiology-and-transmission-risks     PDF     2017-05-28  
 

 

  ASTHMA IN INFANTS AND YOUNG CHILDREN

... ASTHMA IS A CHRONIC INFLAMMATORY DISEASE OF THE AIRWAYS. SYMPTOMS OF ASTHMA ARE VARIABLE. THAT MEANS THAT THEY CAN BE MILD TO SEVERE, INTERMITTENT TO CHRONIC. THE ONE POINT TO REMEMBER IS THAT EVEN WHEN SYMPTOMS ARE MILD, ASTHMA SHOULD NOT BE IGNORED. ...
  asthma-in-infants-and-young-children     PDF     2017-05-27  
 

 

  HEPATITIS B NEWBORN PROPHYLAXIS PROTOCOLS

... THE FOLLOWING HEPATITIS B NEWBORN PROPHYLAXIS PROTOCOLS APPLY TO: A.INFANTS BORN TO HBSAG-POSITIVE MOTHERS B. INFANTS BORN TO UNSCREENED MOTHERS C.INFANTS BORN TO FAMILIES WITH A HOUSEHOLD MEMBER KNOWN TO BE HBSAG-POSITIVE NOTE: AS FOLLOW-UP OF THE NEWBORN IS DETERMINED BY THE PARENT/GUARDIAN’S AREA OF RESIDENCE, WHICH MAY BE IN A FIRST NATIONS INUIT HEALTH JURISDICTION, REFERENCES TO PUBLIC HEALTH OR INSTRUCTIONS FOR REGIONAL PUBLIC HEALTH INCLUDE FIRST NATIONS INUIT HEALTH. ...
  hepatitis-b-newborn-prophylaxis-protocols     PDF     2017-05-27  
 

 

  PREVENTING AND TREATING YOUR BABY’S FLAT HEAD

... UNTIL ABOUT 1 YEAR OF AGE A BABY’S HEAD SHAPE IS FLEXIBLE AND CAN BECOME FLAT AND UNEVEN IF A BABY LIKES TO LOOK IN ONE DIRECTION OR IS ALWAYS ON HIS OR HER BACK. YOU CAN PREVENT THIS. THE MAIN WAY IS TO CHANGE YOUR BABY’S SLEEP AND PLAY POSITION OFTEN DURING THE DAY AND NIGHT. HERE ARE SOME SPECIFIC WAYS HOW TO DO THIS: ...
  preventing-and-treating-your-babys-flat-head     PDF     2017-05-27